Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OmniAb (OABI) Short-term Investments (2022 - 2025)

Historic Short-term Investments for OmniAb (OABI) over the last 4 years, with Q3 2025 value amounting to $31.0 million.

  • OmniAb's Short-term Investments fell 367.71% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.0 million, marking a year-over-year decrease of 367.71%. This contributed to the annual value of $31.8 million for FY2024, which is 5492.25% down from last year.
  • Per OmniAb's latest filing, its Short-term Investments stood at $31.0 million for Q3 2025, which was down 367.71% from $23.3 million recorded in Q2 2025.
  • OmniAb's 5-year Short-term Investments high stood at $90.7 million for Q1 2023, and its period low was $23.3 million during Q2 2025.
  • Over the past 4 years, OmniAb's median Short-term Investments value was $43.2 million (recorded in 2024), while the average stood at $50.9 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 2870.16% in 2023, then tumbled by 5735.78% in 2024.
  • OmniAb's Short-term Investments (Quarter) stood at $54.9 million in 2022, then grew by 28.7% to $70.6 million in 2023, then tumbled by 54.92% to $31.8 million in 2024, then dropped by 2.74% to $31.0 million in 2025.
  • Its Short-term Investments stands at $31.0 million for Q3 2025, versus $23.3 million for Q2 2025 and $32.7 million for Q1 2025.